Mega, Michael S <br/><br/>
Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study.  [electronic resource] 

 -  Archives of neurology  May 2005 
 - 721-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0003-9942 
<br/><br/><label>Standard No.: </label>10.1001/archneur.62.5.721  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alzheimer Disease--drug therapy<br/>Behavioral Symptoms--drug therapy<br/>Brain--drug effects<br/>Brain Mapping<br/>Cognition--drug effects<br/>Female<br/>Fluorodeoxyglucose F18<br/>Functional Laterality<br/>Galantamine--therapeutic use<br/>Humans<br/>Imaging, Three-Dimensional<br/>Male<br/>Mental Status Schedule<br/>Middle Aged<br/>Neuropsychological Tests<br/>Nootropic Agents--therapeutic use<br/>Positron-Emission Tomography--methods<br/>Prospective Studies<br/>Radiopharmaceuticals<br/>Treatment Outcome